Barrow, Hanley, Mewhinney & Strauss’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
Other funds holding ACH
CCM
PCMI
Barrow, Hanley, Mewhinney & Strauss's ACH Position: Q2 2025 in Review
Barrow, Hanley, Mewhinney & Strauss sold out of Accendra Health (ACH) in Q2 2025, closing a stake of 68 shares — an estimated $614 sold.
Barrow, Hanley, Mewhinney & Strauss first reported a position in ACH in Q1 2015 and held it in 22 quarters. The position peaked at $7.29M in Q1 2017. 234 funds tracked by Wall St. Rank hold ACH as of Q2 2025.
- Barrow, Hanley, Mewhinney & Strauss reported no remaining Accendra Health position as of Q2 2025 after selling out during the quarter.
- Barrow, Hanley, Mewhinney & Strauss sold 68 Accendra Health shares in Q2 2025, an estimated $614.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in Accendra Health in Q1 2015 and held it in 22 quarters.
- Barrow, Hanley, Mewhinney & Strauss's Accendra Health position peaked at $7.29M in Q1 2017.
- 234 funds tracked by Wall St. Rank held Accendra Health as of Q2 2025.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2025, filed 12 Aug 2025.